Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is a serious complication affecting up to half of people with scleroderma, and it’s a leading cause of death. New guidelines and ...

Interstitial lung disease (ILD) refers to a group of conditions that cause damage and stiffness in the lung tissue. Over time, this damage can make it harder for oxygen to move into the bloodstream.

From the choice between lobectomy and segmentectomy to managing risks tied to interstitial lung disease, lung surgery decisions require careful thought. Recovery timelines and complication risks vary ...

Patients with interstitial lung disease who are positive for anti-Ku antibody may show progressive fibrotic behavior.

While sex is commonly disclosed in interstitial lung disease trials, data on participant race and ethnicity are infrequently documented.

Patients with inflammatory bowel disease (IBD) had a significantly higher risk for developing interstitial lung disease (ILD) compared with the general population and siblings who do not have the ...